HIGHLIGHTS
- who: August and collaborators from the University of Campania Luigi Vanvitelli, Italy have published the paper: Yang-xin-xue keli exerts therapeutic effects via regulating mitochondrial homeostasis and function in doxorubicin-induced rat heart failure, in the Journal: (JOURNAL)
- what: The authors focused on the evaluation of the efficacy and effects of YXX in the treatment of CHF. This study demonstrated that YXX keli improves cardiac dysfunction and metabolic processes in a rat model of DOX-induced chronic heart failure and in primary rat cardiomyocytes.
SUMMARY
Function (Wang X. et_al, 2017 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.